CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes
- 12 February 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (3) , 390-396
Abstract
Background: Cytologic evaluation of CSF does not consistently detect malignant cells in patients with primary CNS lymphoma (PCNSL). The potentially more sensitive molecular assessment of monoclonality has not been shown in CSF samples. Methods: The authors studied nested PCR of the complementary determining region III (CDR III) on 76 CSF specimens of patients with PCNSL. Patients with systemic disseminated B-cell non-Hodgkin’s lymphoma (n = 17) and 17 patients with no history of lymphoma were compared. PCR products were evaluated by automated fluorescent fragment analysis (ALF). Results: In 68 patients with PCNSL, the authors analyzed the first obtained CSF sample. Nevertheless, 60 patients were taking corticosteroids. In 16 PCNSL samples, amplifiable DNA was not yielded. Taking into account that at least two independent assays have to be performed, CDR III PCR consistently revealed monoclonal products in eight PCNSL and polyclonal results in 52 PCNSL specimens. CDR III PCR detected no monoclonal PCR products in patients without history of lymphoma. In 10 patients with PCNSL, the PCR result and the CSF cytology were discordant. Concerning therapeutic impact, leptomeningeal tumor spread did not predict tumor response in this group of patients with PCNSL. Conclusions: This study performed CDR III PCR as a routine diagnostic technique applicable even on CSF samples with low cell counts. These data present low incidence of leptomeningeal involvement in this subset of pretreated PCNSL patients. Because the CSF evaluation did not predict outcome in our patients, further analysis in patients with PCNSL should focus on CSF samples that are obtained very early after diagnosis.Keywords
This publication has 20 references indexed in Scilit:
- Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitisAnnals of Neurology, 2000
- Detection of Immunoglobulin Heavy Chain Genes Rearrangements in B-Cell Leukemias, Lymphomas, Multiple Myelomas, Monoclonal and Polyclonal GammopathiesLeukemia & Lymphoma, 2000
- Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement by B‐cell lymphoma and leukaemia: a novel strategy and its implicationsBritish Journal of Haematology, 1997
- Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implicationsAnnals of Neurology, 1995
- Routine Application of Polymerase Chain Reaction in the Diagnosis of Monoclonality of B-Cell Lymphoid ProliferationsDiagnostic Molecular Pathology, 1995
- Immunoglobulin heavy chain rearrangements in primary brain lymphomas. A study using PCR to amplify CDR‐IIIThe Journal of Pathology, 1993
- Detection of monoclonality in low‐grade B‐cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma typeThe Journal of Pathology, 1993
- Primary central nervous system lymphomas?an updateJournal of Cancer Research and Clinical Oncology, 1992
- Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspectsClinica Chimica Acta, 1991
- Primary central nervous system lymphomaJournal of Neurosurgery, 1988